Effect of Vitamin D supplementation on selected inflammatory biomarkers in older adults: A secondary analysis of data from a randomised, placebo-controlled trial

British Journal of Nutrition

Volumn 114, Issue 5, 2015, Pages 693-699

  Waterhouse, Mary ^a,b   Tran, Bich ^c   Ebeling, Peter R ^b,d   English, Dallas R ^e,f   Lucas, Robyn M ^g,h   Venn, Alison J ⁱ   Webb, Penelope M ^a   Whiteman, David C ^a,b   Neale, Rachel E ^a,b  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b Centre for Research Excellence in Sun and Health   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f CANCER EPIDEMIOLOGY CENTRE   (Australia)

^g The Australian National University   (Australia)

^h UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

ⁱ UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Adipokines; Cytokines; Supplementation; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ADIPONECTIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHEMOKINE; COLECALCIFEROL; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; LEPTIN; PLACEBO; VITAMIN D; 25-HYDROXYVITAMIN D; ADIPOCYTOKINE; VITAMIN;

ADULT; AGED; ARTICLE; AUSTRALIA; BLOOD SAMPLING; CONTROLLED STUDY; DATA ANALYSIS; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; MALE; OBSERVATIONAL STUDY; RANDOMIZED CONTROLLED TRIAL; SECONDARY ANALYSIS; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION; ANALOGS AND DERIVATIVES; BLOOD; COMPLICATION; DIET SUPPLEMENTATION; METABOLISM; MIDDLE AGED; VITAMIN D DEFICIENCY;

ADIPOKINES; ADIPONECTIN; AGED; BIOMARKERS; C-REACTIVE PROTEIN; CHOLECALCIFEROL; CYTOKINES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-6; LEPTIN; MALE; MIDDLE AGED; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84940596888     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114515002366     Document Type: Article

References (51)

1. Elinav E, Nowarski R, Thaiss CA, et al. (2013) Inflammationinduced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer 13, 759-771.
2. Ross R (1999) Atherosclerosis - an inflammatory disease. N Engl J Med 340, 115-126.
3. Munoz LE, Janko C, Schulze C, et al. (2010) Autoimmunity and chronic inflammation - two clearance-related steps in the etiopathogenesis of SLE. Autoimmun Rev 10, 38-42.
4. van Etten E & Mathieu C (2005) Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol 97, 93-101.
5. D'Ambrosio D, Cippitelli M, Cocciolo MG, et al. (1998) Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest 101, 252-262.
6. Alroy I, Towers TL & Freedman LP (1995) Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol 15, 5789-5799.
7. Menendez C, Lage M, Peino R, et al. (2001) Retinoic acid and vitamin D(3) powerfully inhibit in vitro leptin secretion by human adipose tissue. J Endocrinol 170, 425-431.
8. Sun X & Zemel MB (2007) Calcium and 1,25-dihydroxyvitamin D3 regulation of adipokine expression. Obesity (Silver Spring) 15, 340-348.
9. Bellia A, Garcovich C, D'Adamo M, et al. (2013) Serum 25-hydroxyvitamin D levels are inversely associated with systemic inflammation in severe obese subjects. Intern Emerg Med 8, 33-40.
10. van de Luijtgaarden KM, Voute MT, Hoeks SE, et al. (2012) Vitamin D deficiency may be an independent risk factor for arterial disease. Eur J Vasc Endovasc Surg 44, 301-306.
11. Vilarrasa N, Vendrell J, Maravall J, et al. (2010) Is plasma 25 (OH) D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population? Endocrine 38, 235-242.
12. Kim M, Na W & Sohn C (2013) Correlation between vitamin D and cardiovascular disease predictors in overweight and obese Koreans. J Clin Biochem Nutr 52, 167-171.
13. Vaidya A, Williams JS & Forman JP (2012) The independent association between 25-hydroxyvitamin D and adiponectin and its relation with BMI in two large cohorts: the NHS and the HPFS. Obesity (Silver Spring) 20, 186-191.
14. Husemoen LL, Skaaby T, Martinussen T, et al. (2014) Investigating the causal effect of vitamin D on serum adiponectin using a Mendelian randomization approach. Eur J Clin Nutr 68, 189-195.
15. Khoo AL, Chai LY, Koenen HJ, et al. (2011) Regulation of cytokine responses by seasonality of vitamin D status in healthy individuals. Clin Exp Immunol 164, 72-79.
16. Barker T, Rogers VE, Levy M, et al. (2015) Supplemental vitamin D increases serum cytokines in those with initially low 25-hydroxyvitamin D: a randomized, double blind, placebocontrolled study. Cytokine 71, 132-138.
17. Asemi Z, Samimi M, Tabassi Z, et al. (2013) Vitamin D supplementation affects serum high-sensitivity C-reactive protein, insulin resistance, and biomarkers of oxidative stress in pregnant women. J Nutr 143, 1432-1438.
18. Witham MD, Dove FJ, Khan F, et al. (2013) Effects of vitamin D supplementation on markers of vascular function after myocardial infarction - a randomised controlled trial. Int J Cardiol 167, 745-749.
19. Abou-Raya A, Abou-Raya S & Helmii M (2013) The effect of vitamin D supplementation on inflammatory and hemostatic markers and disease activity in patients with systemic lupus erythematosus: a randomized placebo-controlled trial. J Rheumatol 40, 265-272.
20. Grossmann RE, Zughaier SM, Liu S, et al. (2012) Impact of vitamin D supplementation on markers of inflammation in adults with cystic fibrosis hospitalized for a pulmonary exacerbation. Eur J Clin Nutr 66, 1072-1074.
21. Schleithoff SS, Zittermann A, Tenderich G, et al. (2006) Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 83, 754-759.
22. Neyestani TR, Nikooyeh B, Alavi-Majd H, et al. (2012) Improvement of vitamin D status via daily intake of fortified yogurt drink either with or without extra calcium ameliorates systemic inflammatory biomarkers, including adipokines, in the subjects with type 2 diabetes. J Clin Endocrinol Metab 97, 2005-2011.
23. Barnes MS, Horigan G, Cashman KD, et al. (2011) Maintenance of wintertime vitamin D status with cholecalciferol supplementation is not associated with alterations in serum cytokine concentrations among apparently healthy younger or older adults. J Nutr 141, 476-481.
24. Pittas AG, Harris SS, Stark PC, et al. (2007) The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 30, 980-986.
25. Wood AD, Secombes KR, Thies F, et al. (2012) Vitamin D3 supplementation has no effect on conventional cardiovascular risk factors: a parallel-group, double-blind, placebocontrolled RCT. J Clin Endocrinol Metab 97, 3557-3568.
26. Yusupov E, Li-Ng M, Pollack S, et al. (2010) Vitamin D and serum cytokines in a randomized clinical trial. Int J Endocrinol 2010, 305054.
27. Jorde R, Sneve M, Torjesen PA, et al. (2010) No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects. Cytokine 50, 175-180.
28. Wamberg L, Kampmann U, Stodkilde-Jorgensen H, et al. (2013) Effects of vitamin D supplementation on body fat accumulation, inflammation, and metabolic risk factors in obese adults with low vitamin D levels - results from a randomized trial. Eur J Intern Med 24, 644-649.
29. Carrillo AE, Flynn MG, Pinkston C, et al. (2012) Vitamin D supplementation during exercise training does not alter inflammatory biomarkers in overweight and obese subjects. Eur J Appl Physiol 112, 3045-3052.
30. Jorde R, Strand Hutchinson M, Kjaergaard M, et al. (2013) Supplementation with high doses of vitamin D to subjects without vitamin D deficiency may have negative effects: pooled data from four intervention trials in Tromso. ISRN Endocrinol 2013, 348705.
31. Medzhitov R (2008) Origin and physiological roles of inflammation. Nature 454, 428-435.
32. Trinchieri G (2012) Cancer and inflammation: an old intuition with rapidly evolving new concepts. Annu Rev Immunol 30, 677-706.
33. Tran B, Armstrong BK, Carlin JB, et al. (2012) Recruitment and results of a pilot trial of vitamin D supplementation in the general population of Australia. J Clin Endocrinol Metab 97, 4473-4480.
34. Satoh N, Naruse M, Usui T, et al. (2004) Leptin-to-adiponectin ratio as a potential atherogenic index in obese type 2 diabetic patients. Diabetes Care 27, 2488-2490.
35. Institute of Medicine (2011) Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: The National Academies Press.
36. Hoenig JM & Heisey DM (2001) The abuse of power: the pervasive fallacy of power calculations for data analysis. Am Stat 55, 19-24.
37. Tilg H, Dinarello CA & Mier JW (1997) IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol Today 18, 428-432.
38. Steensberg A, Fischer CP, Keller C, et al. (2003) IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. Am J Physiol Endocrinol Metab 285, E433-E437.
39. Willheim M, Thien R, Schrattbauer K, et al. (1999) Regulatory effects of 1alpha,25-dihydroxyvitamin D3 on the cytokine production of human peripheral blood lymphocytes. J Clin Endocrinol Metab 84, 3739-3744.
40. Gepner AD, Ramamurthy R, Krueger DC, et al. (2012) A prospective randomized controlled trial of the effects of vitamin D supplementation on cardiovascular disease risk. PLOS ONE 7, e36617.
41. Beilfuss J, Berg V, Sneve M, et al. (2012) Effects of a 1-year supplementation with cholecalciferol on interleukin-6, tumor necrosis factor-alpha and insulin resistance in overweight and obese subjects. Cytokine 60, 870-874.
42. Breslavsky A, Frand J, Matas Z, et al. (2013) Effect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients. Clin Nutr 32, 970-975.
43. Zhang Y, Leung DY, Richers BN, et al. (2012) Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol 188, 2127-2135.
44. Barker T, Martins TB, Hill HR, et al. (2013) Circulating pro-inflammatory cytokines are elevated and peak power output correlates with 25-hydroxyvitamin D in vitamin D insufficient adults. Eur J Appl Physiol 113, 1523-1534.
45. Tran B, Armstrong BK, Ebeling PR, et al. (2014) Effect of vitamin D supplementation on antibiotic use: a randomized controlled trial. Am J Clin Nutr 99, 156-161.
46. Bergman P, Lindh AU, Bjorkhem-Bergman L, et al. (2013) Vitamin D and respiratory tract infections: a systematic review and meta-analysis of randomized controlled trials. PLOS ONE 8, e65835.
47. Chel V, Wijnhoven HA, Smit JH, et al. (2008) Efficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing home residents. Osteoporos Int 19, 663-671.
48. Hollis BW & Wagner CL (2013) Clinical review: the role of the parent compound vitamin D with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes. J Clin Endocrinol Metab 98, 4619-4628.
49. Ish-Shalom S, Segal E, Salganik T, et al. (2008) Comparison of daily, weekly, and monthly vitamin D3 in ethanol dosing protocols for two months in elderly hip fracture patients. J Clin Endocrinol Metab 93, 3430-3435.
50. Binkley N, Gemar D, Engelke J, et al. (2011) Evaluation of ergocalciferol or cholecalciferol dosing, 1,600 IU daily or 50,000 IU monthly in older adults. J Clin Endocrinol Metab 96, 981-988.
51. Vieth R (2008) Comment on Chel et al.: efficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing home residents. Osteoporos Int 19, 721-722 (author reply 723).